Osteocytic FGF23 and Its Kidney Function is a research paper published in Frontiers in Endocrinology (2020). On theSindex it has a DataRank of 0. It has been cited 59 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: F31 DK122679
NHLBI NIH HHS
Grant: R01 HL145528
NHLBI NIH HHS
Grant: T32 HL007910
NIDDK NIH HHS
Grant: R01 DK112958
NIAMS NIH HHS
Grant: R21 AR059278
National Institutes of Health
Grant: 1F31DK122679-01
Therapeutic potential of HIF-PHDi in the control of bioactive FGF23 in CKD.
National Institutes of Health
Grant: 5R21AR059278-02
Conditional Isolation of Fgf23 Activity
National Institutes of Health
Grant: 5R01HL145528-02
Changes in phosphate metabolism cause pathologic cardiac remodeling in chronic kidney disease (CKD)
National Institutes of Health
Grant: 5R01DK112958-03
Novel Control of FGF23 in Metabolic Bone Disease
National Institutes of Health
Grant: 2T32HL007910-06
Basic Science Studies on Gene Therapy of Blood Diseases
FWCI
3.91
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
Additional file 1 of A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
Additional file 2 of A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
Additional file 2 of A potential link between fibroblast growth factor-23 and the progression of AKI to CKD